Progyny, Inc. Announces Details for Its Second Quarter 2024 Results Report
Progyny, Inc. (Nasdaq: PGNY), a leading fertility, family building, and women's health benefits solution provider, has announced its plans to report Q2 2024 financial results on August 6, 2024, after market close. The company will host a conference call at 4:45 P.M. ET (1:45 P.M. PT) to discuss the results.
Interested participants can join the call using specific dial-in numbers and passcode. A live webcast and archive of the call will be available on the company's investor relations website. Progyny is recognized for its innovative approach to fertility and women's health benefits, focusing on comprehensive solutions that benefit employers, patients, and physicians while optimizing clinical outcomes and reducing healthcare costs.
Progyny, Inc. (Nasdaq: PGNY), un fornitore leader di soluzioni per la fertilità, costruzione della famiglia e benefici per la salute delle donne, ha annunciato i suoi piani per riportare i risultati finanziari del Q2 2024 il 6 agosto 2024, dopo la chiusura del mercato. L'azienda ospiterà una conferenza telefonica alle 16:45 ET (13:45 PT) per discutere i risultati.
I partecipanti interessati possono unirsi alla chiamata utilizzando numeri di accesso specifici e un codice di accesso. Un webcast dal vivo e un archivio della chiamata saranno disponibili sul sito web per le relazioni con gli investitori dell'azienda. Progyny è riconosciuta per il suo approccio innovativo ai benefici per la fertilità e la salute delle donne, concentrandosi su soluzioni complete che avvantaggiano datori di lavoro, pazienti e medici, ottimizzando al contempo i risultati clinici e riducendo i costi sanitari.
Progyny, Inc. (Nasdaq: PGNY), un proveedor líder de soluciones en fertilidad, construcción de familia y beneficios de salud para mujeres, ha anunciado sus planes para reportar los resultados financieros del Q2 2024 el 6 de agosto de 2024, después del cierre del mercado. La compañía llevará a cabo una conferencia telefónica a las 4:45 P.M. ET (1:45 P.M. PT) para discutir los resultados.
Los participantes interesados pueden unirse a la llamada utilizando números de acceso específicos y un código de acceso. Se dispondrá de un webcast en vivo y un archivo de la llamada en el sitio web de relaciones con inversores de la compañía. Progyny es reconocida por su enfoque innovador en los beneficios de fertilidad y salud de las mujeres, con un enfoque en soluciones integrales que benefician a empleadores, pacientes y médicos, optimizando los resultados clínicos y reduciendo los costos de atención médica.
Progyny, Inc. (Nasdaq: PGNY)는 난임, 가족 형성 및 여성 건강 혜택 솔루션 제공업체로서, 2024년 2분기 재무 결과를 2024년 8월 6일, 시장 마감 후 발표할 계획을 발표했습니다. 회사는 결과를 논의하기 위해 동부 표준시 기준 오후 4시 45분(태평양 표준시 기준 오후 1시 45분)에 컨퍼런스 콜을 개최합니다.
참여를 원하는 분들은 특정 다이얼 번호와 비밀번호를 사용하여 전화를 통해 참여할 수 있습니다. 회사의 투자자 관계 웹사이트에서는 실시간 웹캐스트와 그 콜의 아카이브를 확인할 수 있습니다. Progyny는 고용주, 환자 및 의사에게 유익하고 임상 결과를 최적화하며 의료 비용을 절감하는 포괄적인 솔루션에 중점을 두고 여성 건강 및 가임력 혜택에 대한 혁신적인 접근 방식으로 인정을 받고 있습니다.
Progyny, Inc. (Nasdaq: PGNY), un fournisseur leader de solutions en fertilité, construction de famille et pour la santé des femmes, a annoncé ses projets de rapporter les résultats financiers du T2 2024 le 6 août 2024, après la clôture du marché. La société organisera une conférence téléphonique à 16h45 ET (13h45 PT) pour discuter des résultats.
Les participants intéressés peuvent rejoindre l'appel en utilisant des numéros d'accès spécifiques et un code d'accès. Un webinaire en direct et un archivage de l'appel seront disponibles sur le site Web des relations avec les investisseurs de l'entreprise. Progyny est reconnue pour son approche innovante des avantages en matière de fertilité et de santé des femmes, en mettant l'accent sur des solutions complètes qui bénéficient aux employeurs, aux patients et aux médecins tout en optimisant les résultats cliniques et en réduisant les coûts de santé.
Progyny, Inc. (Nasdaq: PGNY), ein führender Anbieter von Lösungen für Fertilität, Familienplanung und Gesundheitsleistungen für Frauen, hat seine Pläne bekannt gegeben, die Finanzergebnisse für das Q2 2024 am 6. August 2024 nach Marktschluss zu berichten. Das Unternehmen wird um 16:45 Uhr ET (13:45 Uhr PT) eine Telefonkonferenz abhalten, um die Ergebnisse zu besprechen.
Interessierte Teilnehmer können telefonisch über spezifische Einwahlnummern und einen Zugangs-Code an der Konferenz teilnehmen. Eine Live-Webcast-Übertragung und ein Archiv der Sitzung werden auf der Investor Relations-Website des Unternehmens verfügbar sein. Progyny wird für ihren innovativen Ansatz in Bezug auf Fertilitäts- und Gesundheitsleistungen für Frauen anerkannt, wobei der Fokus auf umfassenden Lösungen liegt, die Arbeitgeber, Patienten und Ärzte nutzen können, während klinische Ergebnisse optimiert und Gesundheitskosten gesenkt werden.
- Progyny is planning to report its Q2 2024 financial results, indicating ongoing business operations and transparency
- The company is hosting a conference call to discuss results, showing commitment to investor communication
- Progyny has been recognized as a TIME100 Most Influential Company and CNBC Disruptor 50, suggesting strong market position
- None.
NEW YORK, July 23, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, will report its financial results for the quarterly period ended June 30, 2024 after the close of the market on Tuesday, August 6, 2024.
The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call.
Interested participants in the United States may access the conference call by dialing 1.866.825.7331 and using the passcode 265484. International participants may access the call by dialing 1.973.413.6106 and using the same passcode.
An audio replay of the call will be available through Tuesday, August 13, 2024 and may be accessed by dialing 1.800.332.6854 (U.S. participants) or 1.973.528.0005 (international participants) with the passcode 265484.
A live webcast and archive of the call will be available from the Events and Presentations section of the Company’s website at http://investors.progyny.com.
About Progyny
Progyny (Nasdaq: PGNY) is a transformative fertility, family building and women’s health benefits solution, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For Further Information, Please Contact:
Investors:
James Hart
investors@progyny.com
Media:
Alexis Ford
media@progyny.com
FAQ
When will Progyny (PGNY) report its Q2 2024 financial results?
What time is Progyny's (PGNY) Q2 2024 earnings conference call?
How can investors access Progyny's (PGNY) Q2 2024 earnings call?
What services does Progyny (PGNY) offer?
